Sec. 708. Public workshop on cell therapies

111 words·~1 min read·/bill/117/hr/7667/rds/section-708

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Not later than 3 years after the date of the enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall convene a public workshop with relevant stakeholders to discuss best practices on generating scientific data necessary to further facilitate the development of certain human cell-, tissue-, and cellular-based medical products (and the latest scientific information about such products) that are regulated as drugs under the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. ) and biological products under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ), namely, stem-cell and other cellular therapies.

Connectionstraces to 2

Traces to 2 documents

U.S. Code

Citation graph

cites case law

Sec. 708

Public workshop on cell therapies

U.S.C.§ 301

U.S.C.§ 262

Cites 2Cited by 0 across 0 sources